In 1987, ASI is founded as a reseller of Autodesk software, digital prototyping & design
Michael Golway acquires Advanced Solutions, Inc.
In November 2004, Michael Golway, an entrepreneur and engineer acquires Advanced Solutions, Inc.
The Inflection Point: New Focus on Biofabrication Technology
Michael Golway, P.E. in 2010
Dr. Jay Hoying in 2010
In October 2010, Advanced Solutions President and CEO Michael Golway, P.E. was invited to attend a tour at the Cardiovascular Innovation Institute (CII) in Louisville, Kentucky. It was an impactful professional moment for him - on each floor of the facility, he met brilliant scientists finding solutions for cardiovascular disease.
It was on this tour where he met Dr. James (Jay) Hoying, who had recently made a discovery about microvessel networks that would forever change humanity's understanding of angiogenesis. Michael and Jay became fast friends, a common passion in applying technology to solve problems for the advancement of medical science.
Starting immediately, Michael & Jay partnered with their top scientists and engineers to explore ways to advance the field of tissue engineering.
Between 2011 and 2013, the first conceptual designs for an integrated bio assembly platform (what would become the BioAssemblyBot), software (TSIM), and vascularization techniques began to emerge.
An Idea is Born
In 2012, Michael presented Jay, and others at the CII, a robotic platform that today is the BioAssemblyBot. He asked a question, "If Advanced Solutions could build this robot, would it make a profound and positive difference in helping you advance the science of tissue engineering?"
The response was a resounding "YES!"
Early concept sketches
BioAssemblyBot & TSIM in 2020
In March of 2013, Advanced Solutions, Inc. began investing significant capital into building BioAssemblyBot and setting out on a journey that would teach a robot to 3D print vascularized human organs.
Early proof of concept to demonstrate the six-axes robotic freedom.
In March 2013, Advanced Solutions, Inc. establishes a wholly owned subsidiary called Advanced Solutions Life Sciences, LLC to develop and further science. Detailed engineering and prototyping of the BioAssemblyBot and TSIM system began.
Tested & Used
In March 2014, the first built BioAssemblyBot is tested and used to produce its own components such as packaging and mixing biomaterials.
In November 2015, Michael Golway, inventor, publicly unveils the BioAssemblyBot at Stanford University.
Assembly Begins & BioAssemblyBot's Ship
In January 2016, assembly line and quality control facilities are built. In February 2016, the first commercial BioAssemblyBot ships to Stanford University for 3D bioprinting cardiac models.
BioAssemblyBot Featured in Publication
In November 2016, the BioAssemblyBot is featured in Dr. Ibrahim T. Ozbolat's book, 3D Bioprinting: Fundamentals, Principles, and Applications.
Global Innovation Award
In May 2017, Young Presidents Organization (YPO) recognized Michael Golway with the 2017 Global Innovation Award for the BioAssemblyBot technology platform..
BioAssemblyBot Featured in Second Publication
In May 2017, the BioAssemblyBot is featured in Dr. Kevin Healy's book, Comprehensive Biomaterials II.
CNBC Interviews Michael Golway
In June 2017, CNBC interviews Michael Golway to discuss the BioAssemblyBot and the future of 3D bioprinting human organs.
A Founding Member of BiofabUSA
In November 2017, Advanced Solutions becomes the inaugural tier one member of BiofabUSA, joining the Advanced Regenerative Manufacturing Institute, ARMI, in its mission to make practical large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.
Dr. Jay Hoying joins Advanced Solutions
In January 2018, Dr. Jay Hoying joins Advanced Solutions full-time and is named Chief Scientist.
In March 2018, Advanced Solutions was awarded a patent for BioAssemblyBot.
In April 2018, Advanced Solutions launches Angiomics microvessel technology platform supporting tissue and tissue model vascularization.
Laboratory Opens in Manchester, NH
In June 2018, Advanced Solutions cut the ribbon on a Tissue & Assay Design laboratory in Manchester, NH apart of the Advanced Regenerative Manufacturing Institute.
cGMP Certification Achieved
In July 2018, Advanced Solutions achieved cGMP certification from UL for BioAssemblyBot and BioBot Basic manufacturing.
Expansion into Denver
in October 2018, Advanced Solutions opened an office in Denver, CO at Catalyst Health Tech.
BioAssemblyBot Prints Contoured Skin
In November 2018, Dr. Christophe A. Marquette's 3D FAB announced Contour Skin Printing Platform using BioAssemblyBot.
"Heart Attack Patch" created with BioAssemblyBot
In February 2019, Dr. Vahid Serpooshan created a "heart attack patch" with the BioAssemblyBot.
UL, CE, and CAN Certifications Achieved for BioAssemblyBot
In March 2019, Advanced Solutions achieved UL, CE, and CAN certifications for the BioAssemblyBot.
Ultrasonically-Aligned Human Knee Meniscus
In April 2019, North Carolina State University used a BioAssemblyBot to 3D bioprint and ultrasonically-align human knee meniscus.
Vascularized In-Vitro Perfusion Module Patent Awarded
In August 2019, Advanced Solutions was awarded a patent for vascularized in-vitro perfusion module.
4D Bioprinted Heart Constructs built with BioAssemblyBot
In October 2019, the University of Maryland built a 4D bioprinted heart construct by using BioAssemblyBot.
In October 2019, Advanced Solutions demonstrated 3D tissue constructs using silicone (PDMS).
Advisory Board Established
In October 2019, Advanced Solutions established an Advisory Board with Bill Bastian Jr. and Steve Blum as inaugural members.
Frost & Sullivan Recognizes Advanced Solutions
In November 2019, Frost & Sullivan recognizes Advanced Solutions with the Global 3D Bioprinting Best Practices Award.
New Partnership Announced
In December 2019, Advanced Solutions announced a new partnership with Cytiva, formerly GE Healthcare Life Sciences, for research, development, and distribution.
2020 & Beyond
Innovating for Tomorrow
Advanced Solutions remains committed to always innovating and developing new technologies.